Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open-Reference-Cited by-同舟云学术

Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open

Published:2022-07-21 Issue:10 Volume:37 Page:1884-1892
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Matsuoka Katsuyoshi¹^ORCID,Hisamatsu Tadakazu²^ORCID,Kim Hyo Jong³^ORCID,Ye Byong Duk⁴^ORCID,Arai Shoko⁵^ORCID,Hoshi Masato⁵^ORCID,Yuasa Hirotoshi⁶,Tabira Junichi⁶,Toyoizumi Shigeyuki⁶^ORCID,Shi Nanzhi⁶^ORCID,Woo Joon‐suk⁷,Hibi Toshifumi⁸^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine Toho University Sakura Medical Center Chiba Japan

2. Department of Gastroenterology and Hepatology Kyorin University School of Medicine Tokyo Japan

3. Center for Crohn's and Colitis Kyung Hee University College of Medicine Seoul Korea

4. Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center University of Ulsan College of Medicine Seoul Korea

5. Pfizer Japan Inc Tokyo Japan

6. Pfizer R&D, Japan Tokyo Japan

7. Pfizer Korea Inc Seoul Korea

8. Center for Advanced IBD Research and Treatment Kitasato University Kitasato Institute Hospital Tokyo Japan

Funder

Pfizer

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15923

Reference25 articles.

1. Ulcerative colitis

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

3. Incidence and Prevalence of Inflammatory Bowel Disease across Asia

4. Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

5. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25

2. Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation;Journal of Ethnopharmacology;2024-01

3. Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study;Journal of Crohn's and Colitis;2023-09-01

4. Etrasimod for ulcerative colitis: evaluating phase III results;Nature Reviews Gastroenterology & Hepatology;2023-05-23

5. Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis;Rheumatology;2022-11-28